Talk:Favipiravir

The contents of the Coronavir page were merged into Favipiravir on 11 June 2023. For the contribution history and old versions of the redirected page, please see its history; for the discussion at that location, see its talk page.

The contentious topics procedure applies to this page. This page is related to COVID-19, broadly construed, which has been designated as a contentious topic. Editors who repeatedly or seriously fail to adhere to the purpose of Wikipedia, any expected standards of behaviour, or any normal editorial process may be blocked or restricted by an administrator. Editors are advised to familiarise themselves with the contentious topics procedures before editing this page.

This article is rated C-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects:

Medicine Start‑class Mid‑importance Mid This article has been rated as Mid-importance on the project's importance scale. Pharmacology Mid‑importance This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles Mid This article has been rated as Mid-importance on the project's importance scale. chemicals. To participate, help improve this article or visit the project page for details on the project.ChemicalsWikipedia:WikiProject ChemicalsTemplate:WikiProject Chemicalschemicals articles Low This article has been rated as Low-importance on the project's importance scale.

	COVID-19 Low‑importance
This article is within the scope of WikiProject COVID-19, a project to coordinate efforts to improve all COVID-19-related articles. If you would like to help, you are invited to join and to participate in project discussions.COVID-19Wikipedia:WikiProject COVID-19Template:WikiProject COVID-19COVID-19 articles Low This article has been rated as Low-importance on the project's importance scale.

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Favipiravir. PubMed provides review articles from the past five years (limit to free review articles) The TRIP database provides clinical publications about evidence-based medicine. Other potential sources include: Centre for Reviews and Dissemination and CDC

Archives (index)

1

The article in one section says "had no obvious side effects" and in another says "had serious side effects". This could use some... details!

Matthew Miller (talk) 18:47, 18 March 2020 (UTC)[reply]

For some reason a Russian favipiravir brand (https://www.eapteka.ru/goods/drugs/antiviral/protiv_koronavirusa/koronavir/) is a separate article in Wikipedia:

https://www.eapteka.ru/goods/id492597/

--91.159.188.74 (talk) 01:44, 7 March 2022 (UTC)[reply]

I agree that the two articles should be merged. Coronavir is a brand of favipiravir (see for example https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8661194/). There shouldn't be two articles on the same subject. Marbletan (talk) 15:45, 28 April 2023 (UTC)[reply]

  Y Merger complete.